7-Methoxycoumarin-4-acetyl-pro-leu-gly, with the CAS number 140430-56-4, is a synthetic compound that belongs to the coumarin family, which is characterized by its benzopyrone structure. This compound features a methoxy group at the 7-position and an acetyl group at the 4-position, contributing to its unique chemical properties. The presence of the proline-leucine-glycine peptide sequence suggests that it may exhibit biological activity, potentially influencing various physiological processes. Coumarins are known for their diverse pharmacological effects, including anti-inflammatory, antioxidant, and antimicrobial properties. The specific structural modifications in 7-methoxycoumarin-4-acetyl-pro-leu-gly may enhance its solubility and bioavailability, making it of interest in medicinal chemistry and drug development. Additionally, the compound's interactions with biological targets could be explored for therapeutic applications, particularly in the fields of cancer research and neuroprotection. Further studies would be necessary to fully elucidate its mechanism of action and potential uses in clinical settings.

7-methoxycoumarin-4-acetyl-pro-leu-gly

140430-56-4: 7-Methoxycoumarin-4-acetyl-pro-leu-gly, with the CAS number 140430-56-4, is a synthetic compound that belongs to the coumarin family, which is characterized by its benzopyrone structure. This compound features a methoxy group at the 7-position and an acetyl group at the 4-position, contributing to its unique chemical properties. The presence of the proline-leucine-glycine peptide sequence suggests that it may exhibit biological activity, potentially influencing various physiological processes. Coumarins are known for their diverse pharmacological effects, including anti-inflammatory, antioxidant, and antimicrobial properties. The specific structural modifications in 7-methoxycoumarin-4-acetyl-pro-leu-gly may enhance its solubility and bioavailability, making it of interest in medicinal chemistry and drug development. Additionally, the compound's interactions with biological targets could be explored for therapeutic applications, particularly in the fields of cancer research and neuroprotection. Further studies would be necessary to fully elucidate its mechanism of action and potential uses in clinical settings.

<p>MOCA-Pro-Leu-Gly is a peptide that can bind to the receptor for the neurotransmitter acetylcholine. It is a competitive inhibitor of acetylcholine and has been shown to have an affinity for the nicotinic acetylcholine receptor (nAChR) in vitro. MOCA-Pro-Leu-Gly has been used as a research tool to study protein interactions, as well as to investigate the function of ion channels and receptors. This peptide also has potential therapeutic uses, such as treating Alzheimer's disease by blocking nicotinic acetylcholine receptors in the brain.</p>

CAS 140430-56-4

7-methoxycoumarin-4-acetyl-pro-leu-gly

MOCAc-Pro-Leu-Gly

Ref: 3D-MOC-3164-S